Since overexpression in this system is reported to lead to promiscuous cotranslational modification of accessible lysines29, we endeavored to validate endogenous modification of mTOR in USP18C61A/C61A MEFs that were treated with IFN as a model for in vivo infection. The gene discussed is MTOR; the disease is infection.